COM:GOHEALTH
GoHealth
- Stock
Last Close
11.50
22/11 21:00
Market Cap
101.85M
Beta: -
Volume Today
21.04K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 49.23M - | 78.40M 59.26% | 115.61M 47.46% | 140.59M 21.61% | 77.44M 44.92% | ||
average receivables | 87.04M - | 171.97M 97.57% | 252.17M 46.64% | 313.22M 24.21% | 626.22M 99.93% | ||
book value per share | -8.93 - | 41.14 560.83% | 67.49 64.03% | 49.97 25.96% | 37.66 24.63% | 24.86 33.99% | |
capex per share | -0.30 - | -0.38 29.92% | -2.59 574.90% | -2.80 8.29% | -1.60 42.90% | -1.48 7.64% | |
capex to depreciation | -1.00 - | -0.24 75.74% | -0.15 39.36% | -0.18 24.99% | -0.13 31.44% | -0.13 2.83% | |
capex to operating cash flow | -1.13 - | 2.67K 235,816.30% | 0.13 100.00% | 0.07 47.92% | -0.22 435.02% | -0.13 43.29% | |
capex to revenue | -0.03 - | -0.01 45.53% | -0.02 11.41% | -0.02 12.59% | -0.02 14.77% | -0.02 12.62% | |
cash per share | 0.02 - | 0.59 2,330.89% | 25.70 4,276.77% | 11.94 53.55% | 1.95 83.67% | 9.77 401.28% | |
days of inventory on hand | |||||||
days payables outstanding | 132.41 - | 149.80 13.13% | 159.80 6.68% | 219.61 37.43% | 266.78 21.48% | 24.41 90.85% | |
days sales outstanding | 78.32 - | 84.93 8.44% | 90.86 6.97% | 98.24 8.12% | 196.75 100.28% | 453.07 130.28% | |
debt to assets | 0.04 - | 0.18 419.16% | 0.19 4.36% | 0.34 77.18% | 0.34 0.18% | 0.37 9.73% | |
debt to equity | -0.03 - | 0.34 1,363.77% | 1.06 211.91% | 1.97 86.45% | 1.75 11.12% | 2.39 36.54% | |
dividend yield | 0.00 - | 0.03 - | |||||
earnings yield | 0.00 - | -0.01 246.06% | -0.08 1,156.02% | -1.33 1,473.22% | -4.26 220.72% | -0.51 88.03% | |
enterprise value | 6.11B - | 6.38B 4.50% | 1.41B 77.96% | 1.01B 27.92% | 629.21M 37.93% | 625.50M 0.59% | |
enterprise value over ebitda | 176.78 - | -391.01 321.18% | 26.01 106.65% | 191.90 637.79% | -3.62 101.88% | 16.17 547.31% | |
ev to operating cash flow | 1.12K - | -2.13M 189,699.86% | -12.31 100.00% | -3.39 72.47% | 10.33 404.75% | 5.73 44.53% | |
ev to sales | 27.00 - | 11.83 56.18% | 1.60 86.45% | 0.95 40.47% | 1.00 4.40% | 0.85 14.53% | |
free cash flow per share | -0.03 - | -0.38 1,003.03% | -22.94 5,880.48% | -45.12 96.68% | 5.61 112.44% | 10.27 82.97% | |
free cash flow yield | -0.00 - | -0.00 1,003.03% | -0.11 8,419.77% | -0.79 608.88% | 0.54 167.67% | 0.77 43.33% | |
graham net net | -14.00 - | -30.41 117.28% | -71.56 135.33% | -124.19 73.54% | -94.23 24.13% | -34.35 63.55% | |
graham number | 16.44 - | 42.65 159.44% | 162.17 280.29% | 291.55 79.78% | 194.34 33.34% | 61.71 68.25% | |
income quality | 0.19 - | 0.00 99.96% | 1.18 1,608,495.25% | 0.56 52.37% | -0.16 128.91% | -1.73 966.26% | |
intangibles to total assets | 0 - | 0.73 Infinity% | 0.51 30.13% | 0.29 43.63% | 0.30 4.96% | 0.26 12.35% | |
interest coverage | 128.41 - | 3.99 96.89% | -1.35 133.82% | -3.05 126.11% | -4.93 61.46% | -0.97 80.40% | |
interest debt per share | 0.25 - | 13.56 5,317.39% | 77.25 469.79% | 103.28 33.69% | 72.76 29.55% | 66.97 7.96% | |
inventory turnover | |||||||
invested capital | -0.03 - | 0.34 1,363.77% | 1.06 211.91% | 1.97 86.45% | 1.75 11.12% | 2.39 36.54% | |
market cap | 6.10B - | 6.10B 0% | 1.15B 81.16% | 401.70M 65.07% | 88.25M 78.03% | 123.96M 40.46% | |
net current asset value | -275.46M - | -598.38M 117.23% | -317.82M 46.89% | -747.37M 135.15% | -653.03M 12.62% | -617.48M 5.44% | |
net debt to ebitda | 0.13 - | -17.12 13,231.55% | 4.74 127.70% | 115.85 2,343.43% | -3.11 102.68% | 12.97 517.18% | |
net income per share | 1.34 - | -1.96 246.06% | -17.32 781.67% | -75.60 336.49% | -44.57 41.05% | -6.81 84.73% | |
operating cash flow per share | 0.26 - | -0.00 100.06% | -20.35 14,182,376.72% | -42.32 107.92% | 7.21 117.04% | 11.75 62.87% | |
payables turnover | 2.76 - | 2.44 11.61% | 2.28 6.26% | 1.66 27.24% | 1.37 17.68% | 14.95 992.80% | |
receivables turnover | 4.66 - | 4.30 7.78% | 4.02 6.52% | 3.72 7.51% | 1.86 50.07% | 0.81 56.57% | |
research and ddevelopement to revenue | 0.07 - | ||||||
return on tangible assets | 0.20 - | -0.09 148.19% | -0.09 0.85% | -0.36 285.30% | -0.32 10.36% | -0.06 82.35% | |
revenue per share | 10.82 - | 25.81 138.50% | 156.33 505.79% | 150.36 3.82% | 74.80 50.25% | 79.06 5.70% | |
roe | -0.15 - | -0.05 68.30% | -0.26 437.50% | -1.51 489.50% | -1.18 21.78% | -0.27 76.86% | |
roic | -0.16 - | -0.03 82.03% | -0.04 33.15% | -0.10 151.12% | -0.31 221.12% | -0.08 73.29% | |
sales general and administrative to revenue | 0.12 - | 0.34 178.86% | 0.22 33.59% | 0.09 58.89% | 0.18 99.62% | 0.13 31.33% | |
shareholders equity per share | -8.93 - | 41.14 560.83% | 67.49 64.03% | 49.97 25.96% | 37.66 24.63% | 24.86 33.99% | |
stock based compensation to revenue | 0.25 - | 0.03 89.57% | 0.04 67.24% | 0.03 38.07% | |||
tangible asset value | -186.65M - | -309.19M 65.65% | 323.88M 204.75% | 297.82M 8.04% | 91.09M 69.41% | 9.10M 90.01% | |
tangible book value per share | -8.93 - | -14.79 65.65% | 57.71 490.21% | 42.15 26.97% | 10.79 74.41% | 0.98 90.92% | |
working capital | 6.04M - | 30.70M 408.01% | 264.45M 761.29% | 211.93M 19.86% | 149.10M 29.65% | 106.43M 28.62% |
All numbers in (except ratios and percentages)